Opioid-related deaths in the United States have fallen to their lowest level in nearly a decade, according to a new federal analysis released on Tuesday, October 27, 2026 — the lowest point since a public health emergency over opioids was first declared in 2017.
Source: U.S. Department of Health and Human Services
The findings were announced in Detroit, Michigan, by Health and Human Services Secretary Robert F. Kennedy, Jr., at an event hosted by the Detroit Wayne Integrated Health Network. The analysis comes from HHS's Office of the Assistant Secretary for Planning and Evaluation (ASPE) and was published alongside an article in Health Affairs Forefront.
Fentanyl deaths drove almost the whole decline
ASPE found that unintentional injuries accounted for about 30% of the fall in the overall age-adjusted death rate between 2024 and 2025 — ahead of COVID-19, cancer and heart disease — and that overdoses made up about 73% of that injury decline, according to Becker's Behavioral Health's report on the analysis. Nearly all of the overdose decline, about 96%, came from deaths involving fentanyl and other synthetic opioids, which fell 20.7%, from 45,917 in 2024 to 36,406 in 2025.
Source: Becker's Behavioral Health
The analysts also pointed to a weakening illicit supply. Citing Drug Enforcement Administration data, the report noted that the purity of seized fentanyl powder fell from 19.5% in fiscal year 2023 to 10.3% in fiscal year 2025, while the share of tested fentanyl pills containing a potentially lethal dose dropped from 76% to 29% over the same period.
Prescribing is down by more than half since 2015
The companion ASPE analysis of pharmacy dispensing from March 2015 through March 2026 found that opioid prescriptions dispensed had fallen to 45.3% of their March 2015 level, total opioid dosage dispensed was down to 35.2% of the baseline, and the number of patients receiving prescription opioids through retail pharmacies had fallen to 49.6% of the baseline. At the same time, the number of patients filling prescriptions for buprenorphine or naltrexone — medications used to treat substance-use disorders — rose to 218% of the baseline.
Background: a crisis that peaked at more than 81,000 deaths
The opioid epidemic rose for more than three decades before peaking at 81,806 opioid overdose deaths in 2022, according to figures cited by STAT; by 2025 that toll had fallen to 44,564. Federal milestones along the way included the 2018 SUPPORT for Patients and Communities Act, the Food and Drug Administration's 2023 approval of over-the-counter naloxone, and the 2023 removal of the federal waiver requirement for prescribing buprenorphine. Since 2025 the administration has signed the SUPPORT Reauthorization Act, the DEA has launched its Fentanyl Free America initiative, and in January 2026 the Great American Recovery initiative was established to align prevention, treatment and recovery programs.
HHS credits rightsized prescribing, disruption of the fentanyl supply chain and expanded treatment. The ASPE analysts themselves cautioned that the data do not show what caused the decline, and independent researchers writing in STAT noted that deaths began falling in mid-2023 and that neither naloxone expansion nor treatment growth alone matches the timing and scale of the drop. Awaaz Punjab reports the numbers as official findings and the explanation as debated.
"President Trump has attacked the opioid crisis from every direction — rightsizing opioid prescribing, disrupting the fentanyl supply chain, and expanding treatment and recovery," Secretary Kennedy said. "Those actions are saving lives and driving opioid deaths to the lowest in nearly a decade. We will keep pressing forward until every American struggling with addiction has a real path to recovery and a chance to rebuild a healthy life." HHS Senior Advisor Kathryn Burgum, co-chair of the Great American Recovery, added: "For families living with addiction, saving a life means another birthday, another holiday together, another chance to come home."
For Punjabi and other diaspora families across the United States — including Michigan, where the announcement was made, and the trucking corridors where fentanyl seizures and overdose deaths have been a recurring part of this desk's reporting — the figures mean the deadliest phase of the crisis is easing, but more than 36,000 synthetic-opioid deaths in a single year underline that it is far from over.
What happens next
HHS says the federal push continues through the Great American Recovery initiative and the reauthorized SUPPORT programs, with the DEA's Fentanyl Free America campaign targeting the supply chain. The next test of the trend will come in the CDC's provisional 2026 overdose figures; researchers caution that funding cuts to local harm-reduction and treatment programs could slow or reverse the gains, a warning Awaaz Punjab will track as the data is released.